Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
PCSK9 underexpression
i
Other names:
PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9, NARC-1, Subtilisin/Kexin-Like Protease PC9, NARC1, Convertase Subtilisin/Kexin Type 9 Preproprotein, Hypercholesterolemia, Autosomal Dominant 3, Neural Apoptosis Regulated Convertase 1, Neural Apoptosis-Regulated Convertase 1, Proprotein Convertase 9, HCHOLA3, LDLCQ1, FHCL3
Associations
(8)
News
Trials
C3 | Sensitive
C3 | Resistant
Show legend
Drug categories
Immunotherapy
Cancel
Bladder Cancer
Cutaneous Melanoma
Hepatocellular Cancer
Uveal Melanoma
Urothelial Cancer
Ovarian Cancer
Kidney Cancer
Lung Adenocarcinoma
Immunotherapy
C3
PCSK9 underexpression
|
Bladder Cancer
|
Immunotherapy
C3
PCSK9 underexpression
|
Cutaneous Melanoma
|
Immunotherapy
C3
PCSK9 underexpression
|
Hepatocellular Cancer
|
Immunotherapy
C3
PCSK9 underexpression
|
Uveal Melanoma
|
Immunotherapy
C3
PCSK9 underexpression
|
Urothelial Cancer
|
Immunotherapy
C3
PCSK9 underexpression
|
Ovarian Cancer
|
Immunotherapy
C3
PCSK9 underexpression
|
Kidney Cancer
|
Immunotherapy
C3
PCSK9 underexpression
|
Lung Adenocarcinoma
|
Immunotherapy
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login